Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients [Phase 2]
Phase II study evaluating Pazopanib as a second-line treatment after sunitinib in patients with metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Sunitinib in Metastatic Renal Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: High-dose Bevacizumab in Advanced Renal Carcinoma Patients [Phase 2]
A Phase 2 trial evaluated high-dose bevacizumab in patients with advanced renal cell carcinoma; results were posted December 22, 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 study evaluating Bay 59-8862 in patients with advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer [Phase 2]
A Phase 2 trial of Nexavar (sorafenib) in patients with advanced renal cell carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy [Phase 2]
This Phase 2 clinical trial update evaluates sunitinib in patients with metastatic or locally advanced renal cell carcinoma who are not cand…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma [Phase 1]
Completed Phase 1 dose-escalation study of SGN-75 in CD70-positive non-Hodgkin lymphoma and renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia. [Phase 1]
A Phase 1 trial evaluating sorafenib-induced hypophosphatemia in renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours [Phase 4]
A Phase 4 trial evaluated the effects of dexmedetomidine during radiofrequency ablation of abdominal tumors. The study involving cancers of …
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update evaluating a combination of interleukin-2, interferon-alpha and bevacizumab in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. [Phase 2]
This document reports results from a Phase 2 study of bevacizumab (Avastin) in combination with standard therapy for patients with metastati…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy [Phase 4]
A Phase 4 trial evaluating the effect of hydroxyethyl starch on renal function after laparoscopic nephrectomy was terminated.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 trial comparing two dosing schedules of sunitinib in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Imaging Studies of Kidney Cancer Using 18F-VM4-037 [Phase 2]
The NCI-sponsored Phase 2 imaging trial of the radiotracer 18F-VM4-037 for renal cell carcinoma and other kidney neoplasms has been terminat…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Association Between Hepatitis C Infection and Renal Cell Carcinoma
A completed clinical trial update examining the association between hepatitis C infection and renal cell carcinoma, with colorectal cancer a…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update of ABR-217620 in patients with advanced non-small cell lung cancer, renal cell carcinoma, and pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Sorafenib and RAD001 Renal Cell Carcinoma [Phase 1]
This entry reports a completed Phase 1 trial evaluating the combination of sorafenib and RAD001 (everolimus) in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.
A retrospective Danish cohort study (DARENCA Study 2) analyzes progression-free survival and overall survival in patients with metastatic re…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma [Phase 3]
A Phase 3 trial evaluating sorafenib for advanced renal cell carcinoma has completed, outlining the treatment protocol used in this patient …
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) [Phase 2]
A Phase 2 trial evaluating bevacizumab in combination with everolimus for refractory metastatic renal cell carcinoma has been terminated, wi…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study of CNTO 328 in subjects with metastatic renal cell carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of ramucirumab in metastatic renal cell carcinoma completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity [Phase 2]
A Phase 2 trial evaluated heated chemotherapy delivered into the chest cavity for cancers that have spread to the pleura; the study is compl…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Erlotinib and Cetuximab with or without Bevacizumab in patients with metastatic or unresectable k…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection [Phase 2]
Phase 2 clinical trial evaluating the reproducibility of 18F uptake in solid tumors using PET imaging after intravenous administration of a …